SCHEMBL6650872

SCHEMBL6650872

COc1ccnc(N2CCN(Cc3cccc(F)c3)CC2)n1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.70
KMT2A Q03164 2/20 0.70
MEN1 O00255 1/20 0.70
HSD17B10 Q99714 1/20 0.70
DRD2 P14416 6/20 0.61
DRD4 P21917 6/20 0.61
DRD3 P35462 6/20 0.61
KDM4E B2RXH2 2/20 0.59
GAA P10253 1/20 0.59
MAPT P10636 1/20 0.48
ACHE P22303 1/20 0.48
CASP1 P29466 1/20 0.48
CASP4 P49662 1/20 0.48
CASP5 P51878 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653131 0.86 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1HSD17B10DRD2
SCHEMBL6655678 0.86 KDM4E (0.65) ALDH1A1KMT2AMEN1HSD17B10DRD2
SCHEMBL6652178 0.80 MEN1 (0.64) ALDH1A1KMT2AMEN1DRD2DRD4
SCHEMBL6653873 0.79 POLB (0.68) ALDH1A1KMT2AMEN1KDM4EMAPT
SCHEMBL7501987 0.76 DRD2 (1.00) ALDH1A1KMT2AMEN1HSD17B10DRD2
SCHEMBL6653746 0.76 ALDH1A1 (0.60) ALDH1A1KMT2AHSD17B10KDM4EMAPT
SCHEMBL6660468 0.75 CASP1 (0.62) ALDH1A1DRD4KDM4EGAAACHE
Hydrochloric Acid SCHEMBL6651531 0.75 ALDH1A1 (0.59) ALDH1A1KMT2AHSD17B10KDM4EMAPT
SCHEMBL6649931 0.74 MAPT (0.54) ALDH1A1KMT2AMEN1KDM4EGAA
Hypochlorous Acid SCHEMBL6651534 0.74 ALDH1A1 (0.58) ALDH1A1KMT2AHSD17B10KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1006110-B1 DERIVATIVES OF ACYL-PIPERAZINIL-PYRIMIDINS, PREPARATION THEREOF AND APPLICATION AS MEDICAMENTS ESTEVE LABOR DR (ES) 2004-02-11 EP claimed